Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ablation for the Treatment of Concomitant Atrial Fibrillation in Non-Paroxysmal Patients (ATTAC-AF)

NCT01683045 is registered in ClinicalTrials.gov with Endoscopic Technologies, Inc as lead sponsor.

NCT NCT01683045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01683045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ablation for the Treatment of Concomitant Atrial Fibrillation in Non-Paroxysmal Patients (ATTAC-AF)
Lead sponsor
Endoscopic Technologies, Inc
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 2012
Completion date
May 31, 2014
Enrollment
6 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

persistent atrial fibrillation